Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system
Authors
Keywords
-
Journal
Science Advances
Volume 8, Issue 51, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-12-22
DOI
10.1126/sciadv.add7197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
- (2022) Tyler N. Starr et al. NATURE
- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
- (2022) Jennifer Hammond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication
- (2022) Ulrik Fahnøe et al. Viruses-Basel
- Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 Mpro
- (2022) Son Tung Ngo et al. RSC Advances
- Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines
- (2022) Christina Sølund et al. Vaccines
- Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
- (2022) János András Mótyán et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antibody evasion properties of SARS-CoV-2 Omicron sublineages
- (2022) Sho Iketani et al. NATURE
- Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms
- (2022) Julia M Flynn et al. eLife
- Nirmatrelvir–Ritonavir and Viral Load Rebound in Covid-19
- (2022) Annaliesa S. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rebound of SARS-CoV-2 Infection after Nirmatrelvir–Ritonavir Treatment
- (2022) Michael E. Charness et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376
- (2022) Emmanuel Heilmann et al. Science Translational Medicine
- Overcoming culture restriction for SARS-CoV-2 in human cells facilitates the screening of compounds inhibiting viral replication
- (2021) Santseharay Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro
- (2021) Karen A. Gammeltoft et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
- (2021) Elizabeth A. MacDonald et al. ACS Infectious Diseases
- SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor
- (2021) Anna Offersgaard et al. Vaccines
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
- (2021) Angélica Jayk Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
- (2021) Robert L. Gottlieb et al. NEW ENGLAND JOURNAL OF MEDICINE
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro
- (2021) Yuyong Zhou et al. Viruses-Basel
- Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
- (2021) Yao Zhao et al. Protein & Cell
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
- (2020) Bhupesh Goyal et al. ACS Combinatorial Science
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site
- (2020) Jaeyong Lee et al. Nature Communications
- Comparison of antiviral resistance across acute and chronic viral infections
- (2018) Stephen Mason et al. ANTIVIRAL RESEARCH
- CHARMM36m: an improved force field for folded and intrinsically disordered proteins
- (2016) Jing Huang et al. NATURE METHODS
- Conformational Flexibility of a Short Loop near the Active Site of the SARS-3CLpro is Essential to Maintain Catalytic Activity
- (2016) Chunmei Li et al. Scientific Reports
- Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone ϕ, ψ and Side-Chain χ1 and χ2 Dihedral Angles
- (2012) Robert B. Best et al. Journal of Chemical Theory and Computation
- Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations
- (2012) Wenbo Yu et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations
- (2012) R. Anandakrishnan et al. NUCLEIC ACIDS RESEARCH
- Mutation of Glu-166 Blocks the Substrate-Induced Dimerization of SARS Coronavirus Main Protease
- (2010) Shu-Chun Cheng et al. BIOPHYSICAL JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation